Status:
COMPLETED
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
EngenderHealth
Conditions:
Male Circumcision
HIV Prevention
Eligibility:
MALE
18-54 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the Shang Ring, a novel Chinese device for voluntary medical male circumcision, in order to improve the provision of male circumcision services for HIV prevent...
Detailed Description
Three randomized clinical trials (RCTs) have confirmed the benefit of voluntary medical male circumcision (VMMC) in reducing the acquisition of HIV by circumcised men. In Africa, VMMC is most commonly...
Eligibility Criteria
Inclusion
- Freely consents to participate in the study and signs an informed consent form
- Ages 18 - 54 years
- Uncircumcised
- Good general health
- HIV sero-negative
- Able to understand the study procedures and requirements
- Agrees to return to the health care facility for the full schedule of follow-up visits after his circumcision
Exclusion
- Previous circumcision on examination
- Age \< 18 years or \> 54 years
- Active genital infection, anatomic abnormality or other condition, which in the opinion of the surgeon prevents the man from undergoing a circumcision
- HIV sero-positive
- A condition, which in the opinion of the surgeon contradicts participation in the study
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00993811
Start Date
October 1 2009
End Date
March 1 2010
Last Update
December 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Homa Bay District Hospital
Homa Bay, Kenya